What moved it
How to read these marks1 finding · 1 compound · by evidence strength. No dose is advised.
Plasma phenylalanine concentration
Findings drawn, by strength
1finding · 1 compound
- Very limited1
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
Not pooled · no summary effect · point at a mark · Tab, then the arrow keys
Reported to move it1 finding
- L-threonineMoved: lowersEvidence: Very limitedPaper: PMID 124999922003
- Who
- Patients with hyperphenylalaninemia, placebo-controlled crossover (8 weeks supplement, 8 weeks wash-out, 8 weeks crossed over), on special PHE-free amino acid mixture diets
- Dose studied
- oral L-threonine (THR), approximately 50 mg/kg per day for 8 weeks, against a similar amount of maltodextrin as placebo
Dietary THR supplementation of approximately 50 mg/kg per day resulted in a significant decrease of plasma PHE levels ( P = 0.0234).”
Quoted verbatim from Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.crossover · 8 weeksPermalink
No row matches these filters.
How it is measured
Concentration of phenylalanine in plasma, serum or a dried blood spot, by amino-acid analyser, HPLC, tandem mass spectrometry or an enzymatic assay, fasting or at stated times after a load. The matrix, the assay and the sampling time are recorded with each finding.
Papers about it
As an endpoint1
Show the paperHide the paper
Dietary threonine reduces plasma phenylalanine levels in patients with hyperphenylalaninemia.
Journal of pediatric gastroenterology and nutrition2003PMID 12499992Via: named in the paper, as read
Sources cited
1 paper